Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-27

Clinical Trial Update: Marinol in Trichotillomania or Obsessive Compulsive Disorder [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Marinol in trichotillomania and obsessive-compulsive disorder has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Marinol (dronabinol)

Snippet

Sponsor: University of Chicago | Conditions: Trichotillomania, Obsessive Compulsive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2013-09-27